Results 261 to 270 of about 100,904 (331)

Agreement Between the Harmonized and the Self‐Explanatory Versions of the Revised ALS Functional Rating Scale in a Clinical Setting

open access: yesMuscle &Nerve, Volume 73, Issue 2, Page 250-259, February 2026.
ABSTRACT Introduction/Aims The harmonized version of the ALS Functional Rating Scale ‐ Revised (ALSFRS‐R) is typically administered according to standard operating procedures (SOPs) to ensure procedural consistency. In contrast, obtaining the self‐explanatory (SE) version of the ALSFRS‐R does not include the use of SOPs.
André Maier   +11 more
wiley   +1 more source

The Influence of Ultraprocessed Food Consumption on Energy Intake in Emerging Adulthood: A Controlled Feeding Trial

open access: yesObesity, Volume 34, Issue 2, Page 344-356, February 2026.
ABSTRACT Objective This study examined the impact of a 2‐week eucaloric diet high in ultraprocessed foods (UPF) compared to a diet without UPF (non‐UPF) on ad libitum energy intake (EI) and food selection in individuals aged 18–25. Methods In a randomized, crossover, proof‐of‐concept trial, participants completed two 14‐day controlled feeding periods ...
Maria L. M. Rego   +10 more
wiley   +1 more source

Rapid GC-MS method for screening seized drugs in forensic investigations: optimization and validation. [PDF]

open access: yesFront Chem
Askar AM   +5 more
europepmc   +1 more source

Estimation of the Orexin Receptor Occupancy From Human Plasma Pharmacokinetics of Vornorexant, a Novel Dual Orexin 1/2 Receptor Antagonist for the Treatment of Insomnia

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT Vornorexant is a novel dual orexin receptor antagonist (DORA) for the treatment of insomnia with a short elimination half‐life. Estimation of the human orexin receptor occupancy can provide insight into the duration of the sleep‐promoting effect of DORAs.
Shunsuke Kamigaso   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy